TFS Capital’s Medpace MEDP Stock Holding History

TFS Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,441	Closed	-$245K	–	222
2017 Q2	$245K	Buy	8,441 +673	+9%	+$18.9K	0.1%	391
2017 Q1	$232K	Buy	+7,768	New	+$251K	0.08%	442

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital's MEDP Position: Q3 2017 in Review

TFS Capital sold out of Medpace (MEDP) in Q3 2017, closing a stake of 8,441 shares — an estimated $245K sold.

TFS Capital first reported a position in MEDP in Q1 2017 and held it in 2 quarters. The position peaked at $245K in Q2 2017. 86 funds tracked by Wall St. Rank hold MEDP as of Q3 2017.

TFS Capital reported no remaining Medpace position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 8,441 Medpace shares in Q3 2017, an estimated $245K.
TFS Capital first reported a position in Medpace in Q1 2017 and held it in 2 quarters.
TFS Capital's Medpace position peaked at $245K in Q2 2017.
86 funds tracked by Wall St. Rank held Medpace as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.